Entegris, Inc. · ENTG · FY2026 Q2 · Calendar Q3 2026

Entegris raises MSI outlook as AI-driven demand lifts Q2

The quarter strengthens the case that AI-related semiconductor investment and higher material content are supporting Entegris demand, while execution on capacity, margins, and deleveraging remains important to the forward outlook.

Reported Before market openNASDAQTechnology $23.59B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.93 Consensus $0.82
EPS surprise +13.1% Reported versus consensus
Reported revenue $883.2M Consensus $835.8M
Revenue surprise +5.7% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +15.5% Event window
SPY move +1.8% Same window
Abnormal move +13.7% Stock minus SPY
Volume 1.5× Versus trailing sessions
Subsequent drift -10.4% Up to 20 sessions
ENTGSPY benchmark

Ask FN2 about ENTG FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior quarter, management reported faster growth, raised its MSI outlook, highlighted stronger AI-driven demand, and accelerated debt reduction. The company also exited its Life Sciences Fluid Management business and continued footprint rationalization.

Guidance delta

Management raised its MSI growth outlook to 7–8%.

Key takeaways

  • Revenue grew 11% year over year and exceeded guidance.
  • AI-related semiconductor capex, wafer starts, and technology transitions supported demand across both major businesses.
  • Free cash flow of $120 million enabled an additional $200 million debt repayment, while management targeted net leverage below 3x by year-end.

Management priorities

  • Expand capacity and unlock network throughput ahead of demand.
  • Broaden coverage of the top 35 customers through an enterprise sales team.
  • Pursue growth in advanced packaging and specialty coatings.
  • Rationalize the portfolio and facilities while maintaining supply availability.

Follow ENTG with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ENTG EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 2 future estimate-only quarters. Q4 '23 estimate $0.59 Q4 '23 actual $0.65, beat Q1 '24 estimate $0.61 Q1 '24 actual $0.68, beat Q2 '24 estimate $0.70 Q2 '24 actual $0.71, match Q3 '24 estimate $0.79 Q3 '24 actual $0.77, miss Q2 '25 estimate $0.65 Q2 '25 actual $0.66, beat Q3 '25 estimate $0.72 Q3 '25 actual $0.72, match Q4 '25 estimate $0.67 Q4 '25 actual $0.70, beat Q1 '26 estimate $0.74 Q1 '26 actual $0.86, beat Q3 '26 estimate $1.03 Q3 '26 actual $1.23, beat Q4 '26 estimate $1.12 Q1 '27 estimate $1.11
Show less

Analyst Consensus ?

ConsensusBuy28 ratings
Bullish2071.4%
Neutral725.0%
Bearish13.6%

Analyst 52W Price Targets

$154.39Current
$86Low
$157.37Average
$220High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Truist Securities Buy BuyMaintainOct 30, 2026
Needham Buy BuyMaintainOct 30, 2026
Goldman Sachs Sell SellMaintainOct 30, 2026
Citigroup Buy BuyMaintainOct 30, 2026
Barclays Overweight OverweightMaintainOct 30, 2026
Show 23 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $154.39. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSTimothy Arcuri$220$160 +42.5%Oct 30, 2026
Truist FinancialAnalyst unavailable$190$161.16 +23.1%Oct 14, 2026
BarclaysAleksey Yefremov$212$160.01 +37.3%Oct 12, 2026
Stifel NicolausAnalyst unavailable$200$166.32 +29.5%Oct 7, 2026
Deutsche BankMelissa Weathers$200$150.21 +29.5%Aug 12, 2026
See 44 more

Track every rating change on ENTG the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Entegris, Inc. is a global enterprise that develops, manufactures, and supplies critical solutions for microcontamination control, specialty chemicals, and advanced material handling. The company operates extensively across North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. Its operations are structured into three primary segments: Specialty Chemicals and Engineered Materials (SCEM): This division delivers high-performance, ultra-pure process chemistries, specialized gases, and advanced materials, along with their associated delivery systems, crucial for semiconductor fabrication and other sophisticated manufacturing processes. Microcontamination Control (MC): The MC unit focuses on providing systems designed to filter and purify essential liquid chemicals and gases utilized within the semiconductor industry and various other high-technology sectors.…

Historical context

All ENTG earnings

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the ENTG recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-04T21:12:33.310376+00:00
  2. FN2 earnings calendar · 2026-09-09T01:23:14.388487+00:00
  3. Polygon adjusted daily market bars · 2026-10-31T07:20:41.844291+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-31T07:20:41.841500+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.